Nebius (NBIS) › Analysis

Nebius (NBIS) stock analysis, December 8, 2025: NBIS tests $95–$100 support after $140 peak, with $20B contracts vs $4.5B debt

Published December 8, 2025 · NBIS chart, levels and live analysis

Executive Summary

Nebius shares declined -2.37% to $97.14 since the last report, breaking below the $100 psychological support level for the second time in four sessions and extending the pullback to -12.71% over the past month. Despite this near-term weakness, the stock maintains an exceptional YTD gain of +250.69% and has doubled over six months (+101.20%), supported by transformative hyperscaler contracts with Microsoft and Meta totaling over $20 billion. The investment thesis remains fundamentally intact as analyst commentary reinforces confidence in the company's AI infrastructure positioning, though mounting concerns about cash burn, leverage exceeding $4.5 billion, and aggressive valuation multiples warrant heightened monitoring of execution risk.

Key Updates

Nebius shares retreated -2.37% to $97.14, surrendering the $100 psychological threshold and marking a cumulative decline of -12.71% over the past month. This represents the third significant pullback in the past week, with the stock oscillating around the critical $100 level without establishing sustained support. The decline occurred against a backdrop of one new bullish article highlighting the investment case, suggesting technical profit-taking rather than fundamental deterioration is driving the weakness. Volume patterns indicate consolidation after the extraordinary rally from the Microsoft and Meta contract announcements, with the stock digesting gains while maintaining support above the $95 level established in late November.

Current Trend

The YTD performance of +250.69% positions Nebius among the top-performing technology stocks in 2025, with the six-month return of +101.20% demonstrating accelerating momentum in the second half of the year. However, recent price action reveals increasing volatility, with the stock declining -12.71% over the past month following a peak near $140 in November. Key technical levels include resistance at $100-$102 (now acting as overhead supply), intermediate support at $95-$97 (current trading range), and critical support at $85-$90 (representing the pre-Meta deal announcement levels). The stock has formed a descending pattern from recent highs, testing support multiple times without decisive breakdown, suggesting accumulation by institutional investors during weakness rather than distribution.

Investment Thesis

The investment thesis centers on Nebius's position as a rapidly scaling AI infrastructure provider capturing outsized demand from hyperscaler partnerships. The company has secured over $20 billion in multi-year contracts with Microsoft ($17.4 billion) and Meta ($3 billion), positioning it to generate $7-9 billion in annualized revenue by end-2026 from approximately $551 million as of September 2025. This represents a 12-16x revenue expansion within 15 months, driven by nearly full utilization of computing capacity and aggressive buildout targeting 2.5 gigawatts by end-2026. The thesis assumes Nebius can successfully execute its capital-intensive expansion plan, convert contracted revenue into positive cash flow, and maintain pricing power in an increasingly competitive AI infrastructure market. Critical to the thesis is the company's ability to achieve EBITDA profitability while managing debt levels exceeding $4.5 billion and navigating potential dilution from the recently announced at-the-market equity offering of up to 25 million Class A shares.

Thesis Status

The investment thesis remains fundamentally intact but faces heightened execution risk. New analyst commentary from the bullish thesis published December 4th reinforces confidence in the company's strategic positioning, while the December 3rd confirmation of the Meta deal structure validates the $3 billion contract value over five years. However, mounting concerns articulated in recent analyses highlight three emerging risks: (1) circular financing structures that may inflate apparent demand, (2) cash burn dynamics with net losses expanding to $119.6 million in Q3 from $39.7 million year-over-year despite 355% revenue growth, and (3) aggressive valuation at 5x price-to-book versus 3.4x industry average. The downward revision in consensus price targets from $166 to $159 reflects balanced optimism tempered by increasing caution around execution and volatility risks. The thesis progression from "high conviction" to "qualified conviction" is appropriate given the company's transition from contract announcement phase to execution and delivery phase.

Key Drivers

The primary catalyst remains the $3 billion Meta Platforms AI infrastructure agreement announced in Q3 results, following the September 2025 Microsoft contract. Revenue growth of 355% year-over-year to $146.1 million demonstrates exceptional top-line momentum, though slightly below analyst expectations of $155.1 million. The company reported near-full utilization of computing capacity and targets $7-9 billion annualized revenue run rate by end-2026, representing 12-16x expansion from current levels. However, operational execution challenges are evident in expanding net losses and capital expenditures surging to $955.5 million from $172.1 million as the company invests heavily in Nvidia GPUs and data center infrastructure. Institutional investor activity shows hedge funds increasing positions despite the 30% decline from peaks, suggesting sophisticated investors view current levels as attractive entry points. The critical question of cash runway versus cash flow inflection remains the dominant near-term uncertainty, with the company's ability to convert contracted revenue into positive operating cash flow determining whether the current valuation is justified.

Technical Analysis

Nebius is trading at $97.14, positioned -30.5% below the recent peak near $140 established in November following the Meta deal announcement. The stock has tested the $95-$100 range three times in the past week without decisive breakdown, suggesting this zone represents intermediate-term support established by institutional accumulation. Key resistance levels include $100-$102 (psychological barrier and former support), $110-$115 (20-day moving average zone), and $125-$130 (50% retracement of the decline from peaks). Support levels are identified at $95-$97 (current range), $85-$90 (pre-Meta announcement levels), and $75-$80 (September consolidation zone). The relative strength index likely indicates oversold conditions following the -12.71% monthly decline, while volume patterns suggest distribution has slowed, consistent with a consolidation phase rather than the beginning of a sustained downtrend. The stock's ability to hold above $95 while digesting the extraordinary YTD gain of +250.69% demonstrates underlying strength, though a break below $90 would signal more significant technical deterioration requiring reassessment.

Bull Case

Bear Case

Get a message when the NBIS picture changes — the agent team watches the levels and the news for you.Create a free account

More NBIS analyses